139 related articles for article (PubMed ID: 33127959)
1. HIV- and HCV-specific markers and echocardiographic pulmonary artery systolic pressure among United States veterans.
Zola CE; Duncan MS; So-Armah K; Crothers KA; Butt AA; Gibert CL; Kim JWW; Lim JK; Re VL; Tindle HA; Freiberg MS; Brittain EL
Sci Rep; 2020 Oct; 10(1):18729. PubMed ID: 33127959
[TBL] [Abstract][Full Text] [Related]
2. Risk of echocardiographic pulmonary hypertension in individuals with human immunodeficiency virus-hepatitis C virus coinfection.
Sangal RB; Taylor LE; Gillani F; Poppas A; Klinger JR; Ventetuolo CE
Ann Am Thorac Soc; 2014 Dec; 11(10):1553-9. PubMed ID: 25375659
[TBL] [Abstract][Full Text] [Related]
3. Increased Echocardiographic Pulmonary Pressure in HIV-infected and -uninfected Individuals in the Veterans Aging Cohort Study.
Brittain EL; Duncan MS; Chang J; Patterson OV; DuVall SL; Brandt CA; So-Armah KA; Goetz M; Akgun K; Crothers K; Zola C; Kim J; Gibert C; Pisani M; Morris A; Hsue P; Tindle HA; Justice A; Freiberg M
Am J Respir Crit Care Med; 2018 Apr; 197(7):923-932. PubMed ID: 29131651
[TBL] [Abstract][Full Text] [Related]
4. Association between HIV and incident pulmonary hypertension in US Veterans: a retrospective cohort study.
Duncan MS; Alcorn CW; Freiberg MS; So-Armah K; Patterson OV; DuVall SL; Crothers KA; Re VL; Butt AA; Lim JK; Kim JW; Tindle HA; Justice AC; Brittain EL
Lancet Healthy Longev; 2021 Jul; 2(7):e417-e425. PubMed ID: 34296203
[TBL] [Abstract][Full Text] [Related]
5. A prospective evaluation of pulmonary, systemic and hepatic haemodynamics in HIV-HCV-coinfected patients before and after antiviral therapy with pegylated interferon and ribavirin.
Reiberger T; Payer BA; Ferlitsch A; Sieghart W; Breitenecker F; Aichelburg MC; Schmied B; Rieger A; Trauner M; Peck-Radosavljevic M;
Antivir Ther; 2012; 17(7):1327-34. PubMed ID: 22948263
[TBL] [Abstract][Full Text] [Related]
6. Antiretroviral therapy and sustained virological response to HCV therapy are associated with slower liver fibrosis progression in HIV-HCV-coinfected patients: study from the ANRS CO 13 HEPAVIH cohort.
Loko MA; Bani-Sadr F; Valantin MA; Lascoux-Combe C; Fontaine H; Bonnard P; Gervais A; Bouchaud O; Garipuy D; Quertainmont Y; Vittecoq D; Tehrani MS; Winnock M; Dabis F; Salmon D;
Antivir Ther; 2012; 17(7):1335-43. PubMed ID: 23052829
[TBL] [Abstract][Full Text] [Related]
7. Characterization of CD4⁺ T-cell immune activation and interleukin 10 levels among HIV, hepatitis C virus, and HIV/HCV-coinfected patients.
Hodowanec AC; Brady KE; Gao W; Kincaid SL; Plants J; Bahk M; Landay AL; Huhn GD
J Acquir Immune Defic Syndr; 2013 Nov; 64(3):232-40. PubMed ID: 24131865
[TBL] [Abstract][Full Text] [Related]
8. Impact of hepatitis C viral replication on CD4+ T-lymphocyte progression in HIV-HCV coinfection before and after antiretroviral therapy.
Potter M; Odueyungbo A; Yang H; Saeed S; Klein MB;
AIDS; 2010 Jul; 24(12):1857-65. PubMed ID: 20479633
[TBL] [Abstract][Full Text] [Related]
9. Impact of CD4+ blood cell count and HIV viral load on treatment response with direct acting antivirals in HIV and HCV coinfected patients: insights from the German Hepatitis C-Registry.
Bischoff J; Mauss S; Cordes C; Lutz T; Scholten S; Cornberg M; Manns MP; Baumgarten A; Rockstroh JK
HIV Clin Trials; 2018 Dec; 19(6):225-234. PubMed ID: 30890063
[TBL] [Abstract][Full Text] [Related]
10. Cardiopulmonary function in individuals with HIV infection in the antiretroviral therapy era.
Morris A; Gingo MR; George MP; Lucht L; Kessinger C; Singh V; Hillenbrand M; Busch M; McMahon D; Norris KA; Champion HC; Gladwin MT; Zhang Y; Steele C; Sciurba FC
AIDS; 2012 Mar; 26(6):731-40. PubMed ID: 22210636
[TBL] [Abstract][Full Text] [Related]
11. HCV Specific IL-21 Producing T Cells but Not IL-17A Producing T Cells Are Associated with HCV Viral Control in HIV/HCV Coinfection.
MacParland SA; Fadel SM; Mihajlovic V; Fawaz A; Kim C; Rahman AK; Liu J; Kaul R; Kovacs C; Grebely J; Dore GJ; Wong DK; Ostrowski MA
PLoS One; 2016; 11(4):e0154433. PubMed ID: 27124305
[TBL] [Abstract][Full Text] [Related]
12. HIV antibodies level as a marker of HIV persistence: the role of hepatitis C virus coinfection.
Arca-Suarez J; Corrales-Cuevas M; Pascual-Pérez S; Trujillo-Soto T; Fernández-Gutiérrez Del Álamo C; Cuesta-Sancho S; Rodríguez-Iglesias M; Girón-González JA
Eur J Clin Microbiol Infect Dis; 2020 Aug; 39(8):1503-1512. PubMed ID: 32232689
[TBL] [Abstract][Full Text] [Related]
13. Higher Activation in CD4(+) T Cells But Similar Viral Control Among HIV/Hepatitis C Virus-Coinfected Patients on a Simplification Monotherapy.
BenMarzouk-Hidalgo OJ; Torres-Cornejo A; Gutierrez-Valencia A; Ruiz-Valderas R; Viciana P; López-Cortés LF
AIDS Res Hum Retroviruses; 2016 Jan; 32(1):6-11. PubMed ID: 26414169
[TBL] [Abstract][Full Text] [Related]
14. Modelling CD4 T Cell Recovery in Hepatitis C and HIV Co-infected Children Receiving Antiretroviral Therapy.
Majekodunmi AO; Thorne C; Malyuta R; Volokha A; Callard RE; Klein NJ; Lewis J;
Pediatr Infect Dis J; 2017 May; 36(5):e123-e129. PubMed ID: 28403051
[TBL] [Abstract][Full Text] [Related]
15. HCV viraemia associates with NK cell activation and dysfunction in antiretroviral therapy-treated HIV/HCV-co-infected subjects.
Papasavvas E; Azzoni L; Yin X; Liu Q; Joseph J; Mackiewicz A; Ross B; Lynn KM; Jacobson JM; Mounzer K; Kostman JR; Montaner LJ
J Viral Hepat; 2017 Oct; 24(10):865-876. PubMed ID: 28419653
[TBL] [Abstract][Full Text] [Related]
16. Association of HIV, Hepatitis C Virus, and Liver Fibrosis Severity With the Enhanced Liver Fibrosis Score.
Swanson S; Ma Y; Scherzer R; Huhn G; French AL; Plankey MW; Grunfeld C; Rosenberg WM; Peters MG; Tien PC
J Infect Dis; 2016 Apr; 213(7):1079-86. PubMed ID: 26621911
[TBL] [Abstract][Full Text] [Related]
17. Impact of Hepatitis C Virus on the Circulating Levels of IL-7 in HIV-1 Coinfected Women.
Kerzerho J; McIlvaine EJ; Anthony P; Mack WJ; Wang CH; Frederick T; Operskalski E; Chen Z; Al-Harthi L; Landay A; Young MA; Tien PC; Augenbraun M; Strickler HD; Akbari O; Golub ET; Sharp GB; Kovacs A
J Acquir Immune Defic Syndr; 2016 Feb; 71(2):172-80. PubMed ID: 26761519
[TBL] [Abstract][Full Text] [Related]
18. Hepatic compartmentalization of exhausted and regulatory cells in HIV/HCV-coinfected patients.
Barrett L; Trehanpati N; Poonia S; Daigh L; Sarin SK; Masur H; Kottilil S
J Viral Hepat; 2015 Mar; 22(3):281-8. PubMed ID: 25174689
[TBL] [Abstract][Full Text] [Related]
19. Complementary role of HCV and HIV in T-cell activation and exhaustion in HIV/HCV coinfection.
Feuth T; Arends JE; Fransen JH; Nanlohy NM; van Erpecum KJ; Siersema PD; Hoepelman AI; van Baarle D
PLoS One; 2013; 8(3):e59302. PubMed ID: 23555014
[TBL] [Abstract][Full Text] [Related]
20. Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection.
Lo Re V; Volk J; Newcomb CW; Yang YX; Freeman CP; Hennessy S; Kostman JR; Tebas P; Leonard MB; Localio AR
Hepatology; 2012 Nov; 56(5):1688-98. PubMed ID: 22619086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
